Vertex (VRTX) Director Bruce I. Sachs Receives 2,866-Share Award

What Happened Bruce I. Sachs, a director of Vertex Pharmaceuticals (VRTX), was granted an award of 2,866 derivative shares on May 1, 2026. The filing shows $0.00 per share (no purchase price) and classifies the transaction as an award/acquisition (code A). A footnote indicates the award is fully vested.

Key Details

• Transaction date: 2026-05-01; filing date (Form 4): 2026-05-05 (filed within required two business days).
• Amount: 2,866 shares; price reported: $0.00; total cash exchanged: $0.
• Security type: reported as "Derivative" (award/acquisition).
• Footnote F1: award is fully vested.
• Shares owned after transaction: not specified in the filing.

Context This is a compensation-related award to a company director (common for board pay). The filing does not show a sale or cash purchase, nor indicate any immediate disposition of the shares. Such awards are routine and do not, by themselves, signal the insider’s view on the stock.